Navigation Links
Chicago's Top Minds Join National Business and Health Leaders in Addressing Medical Innovation, Highlighting Policies Needed to Maintain U.S. Competitiveness in Medical Science and Discovery

Richard Gephardt and the Council for American Medical Innovation Host "Best and Brightest Forum on Medical Innovation" in Chicago, featuring David Brennan, CEO of AstraZeneca, David Miller, President and CEO of iBIO, academics and patient advocates

CHICAGO, April 15 /PRNewswire-USNewswire/ -- Today in Chicago, the "Best and Brightest Forum on Medical Innovation" convened local and national leaders in academia, biotechnology and patient advocacy to address the importance of medical innovation in America. Richard Gephardt, former majority leader of the U.S. House of Representatives, moderated the forum, which was hosted by the Council for American Medical Innovation, a coalition of leaders in research, medicine, public health, academia, education, labor, and business, working in partnership toward a national policy agenda aimed at preserving U.S. leadership in medical innovation.


"Medical innovation has an enormous impact on the health and economy of the United States, and is a growing part of the economy in Illinois," said Gephardt. "Yet America's lead in science and technology is starting to slip. We need to act now by laying a strong foundation with intelligent policies that will preserve our leadership in medical innovation and allow science and medical discovery to flourish today, tomorrow, and into the future."

Medical innovation is an important source of employment and output in Illinois, where the biopharmaceutical sector supported a total of 181,788 jobs and $37.9 billion in output in 2006, according to a new study conducted by Archstone Consulting and Dr. Lawton R. Burns, Director, The Wharton Center for Health Management and Economics at The Wharton School, University of Pennsylvania. This study also found:

  • Biopharmaceutical sector companies invested $2.0 billion in research and development in Illinois in 2006.
  • Direct biopharmaceutical wages in Illinois were estimated to be $3.9 billion in 2006, resulting in an estimated $1.0 billion in federal taxes and $107.3 million in state taxes.
  • In 2008, U.S. scientists and researchers were conducting 21,795 studies to develop medicines targeting cancers, rare diseases, and other important conditions. Of these trials, 3,286 (15% of U.S. trials) were active in Illinois.

Speakers at today's forum discussed the economic importance of medical innovation to the state of Illinois, and the public policies that will make Illinois a good place to conduct world-class life sciences research and business in coming years.

"As Illinois realizes its potential in the important realm of medical innovation, every part of the state will benefit from new jobs, wealth, and breakthrough discoveries," said David Miller, President and CEO of the Illinois Biotechnology Industry Organization. "Biotechnology and medical discovery provide life-saving and life-enhancing medicines not just for Illinois, but for people all over the world. To realize its potential, Illinois needs good legislation and regulatory practices, sound public investments in programs and infrastructure, effective corporate actions, and support for research centers generating commercializable technology."

Panelists also outlined specific policy changes that are needed at the national level in order to create a healthy environment for innovation and discovery - including policies that can attract companies and well-paying jobs to the U.S., promote risk-taking in research and development, encourage more students to participate in science, technology, engineering and mathematics (STEM) education, attract the best and brightest researchers to the U.S., and support basic scientific research and development.

"Innovative medicines improve patient health and will reduce government health care spending," said David Brennan, CEO of AstraZeneca and Chairman of the Executive Board of the Pharmaceutical Research and Manufacturers of America (PhRMA). "We need government assistance for research that helps bring medicines from the laboratory to the patient in a consistent, systematic way. We need an environment that includes strong, well-defined intellectual property rights, a productive NIH, a robust research-based and patient-driven biopharmaceutical industry, and a strong, well-functioning FDA."

Panelists participating in today's forum included top minds in academia, industry, and patient advocacy:

  • David Brennan, CEO of AstraZeneca
  • Chris Coburn, Executive Director of Cleveland Clinic Innovations
  • Bart Kamen, M.D., Ph.D., Chief Medical Officer of the Leukemia & Lymphoma Society
  • Alicia Loffler, Ph.D., Director of the Kellogg Center for Biotechnology Management, Kellogg School of Management, Northwestern University
  • David Miller, President and CEO of the Illinois Biotechnology Industry Organization

About the Council for American Medical Innovation

The United States faces serious challenges to maintaining its leadership position in innovation. The Council for American Medical Innovation is bringing together leaders in research, medicine, public health, academia, education, labor, and business, who are working in partnership toward a national policy agenda aimed at preserving U.S. leadership in medical innovation. American medical innovators create millions of high-paying jobs, and their discoveries are integral in the fight to cure cancer and other illnesses. The Council for American Medical Innovation views leadership in medical innovation as a key part of America's economic recovery, future prosperity and health.

For more information on the Council for American Medical Innovation, visit

SOURCE Council for American Medical Innovation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Governor Rendell Reminds Families of Resources to Help Avoid Foreclosures, Provide Relief
2. EuroPRevent 09: Changing hearts and minds in the drive to prevent cardiovascular disease
3. ASGEs Birthday e-Card Reminds Recipients to Get Screened for Colorectal Cancer!
4. Mindset Marketing Solutions Partners with Platform-A, ValueClick Media, AdRX Media, Datran Media and Morefocus Media
5. New Super Bowl Ad Reminds Minnesotans: We All Pay the Price for Tobacco
6. Pennsylvania Health Department Reminds Parents to Immunize Their Children Against Pertussis
7. Best Minds, Best Practices in Medicine Conference on Nov. 11
8. Experts call for radical new mindset for health policy
9. Financial Crisis Looms on Minds of Voters; Affordability of Health Care Major Concern as They Head to the Polls
10. PA Health Department Reminds Pennsylvanians to Get a Flu Shot
11. Smart Minds Start With Healthy Mouths
Post Your Comments:
(Date:10/9/2015)... ... ... Head Over Heels Athletic Arts gymnast, Madelyn Williams, will attend the USA ... Huntsville, Texas on October 17-21. , "It's very exciting to be invited to ... director, said. “It's a stepping stone into the U.S. elite system where Maddie and ...
(Date:10/9/2015)... ... October 09, 2015 , ... The Asthma and Allergy ... Centers for Disease Control and Prevention (CDC) to improve the knowledge and skills of ... has been awarded a project by the CDC and allows AAFA to continue vital ...
(Date:10/9/2015)... ... 09, 2015 , ... "As a nurse, I care for male patients who ... to wear large diapers or pads. We came up with this as a better ... urine leaking from the tip of the penis. This prevents stains from forming on ...
(Date:10/9/2015)... ... October 09, 2015 , ... ViewPoint Center, a teen ... many teenagers facing mental illness, the stigma associated with mental illness causes many to ... Center understands the importance of supporting teens with mental illness , providing teens ...
(Date:10/9/2015)... ... October 09, 2015 , ... Deadly, record-smashing rainfall ... Community Foundation (CCCF) in Columbia, South Carolina. In response, the Foundation has established ... victims – both short and long term. 100% of monies donated will go ...
Breaking Medicine News(10 mins):
... Government plans to hasten patient treatment has included bestowing ... drugs//. ,Under this plan, nurses and pharmacists ... for common illnesses that range from acne to tonsillitis. ... clinics and will soon be able to prescribe drugs ...
... industry a panel comprising European experts recommended Sanofi-Aventis's anti-obesity pill ... news was brought to light by the company itself. ... block a pleasure centre and so fight obesity. People on ... with eating. ,Data from a trial involving more ...
... College of Nursing congress last week shouted at Patricia Hewitt ... their hostility to a government which was a great ally ... and what are they furious about? There are 70,000 nurses ... has also risen considerably over the past three years. Les ...
... in the May issue of the journal Medical Care say ... alright to discuss religion with their patients.// However, only three ... beliefs and only half of them bother to query a ... ten physicians routinely mentions his or her religious beliefs and ...
... the rain, there seems to be enough shine, making Washington, ... to the Environmental// Protection Agency. , ,The ... to schools that comprise of 40 activity cards and a ... the sun's UV rays. , ,Demonstrators apply ...
... occur in children whose mothers report difficulties with substance ... delivery, reports a study published in the Archives of ... / mood disorders, smoking, maternal drinking, substance or drug ... that can contribute to behavior problems in children. Although ...
Cached Medicine News:
(Date:10/9/2015)... CINCINNATI , Oct. 9, 2015  Xavier ... Thinking labs with Konica Minolta Medical Imaging (KMMI) on ... utilize Design Thinking to help healthcare providers imagine and ... a visual roadmap that they can customize for their ... Primary Imaging is the initial procedure, or study, in ...
(Date:10/9/2015)... 2015 ® ) ... Kolonoskopie im Rahmen eines Screenings, einer beobachtenden ... bewertete auch die Compliance, Sicherheit, Patientenakzeptanz und ... ) an erwachsenen Patienten vergleicht, die sich ... beobachtenden oder einer diagnostischen Kolonoskopie unterziehen. Die ...
(Date:10/9/2015)... BETHESDA, Maryland , October 9, 2015 ... Pharmaceuticals Inc. (OTCQB: CNBX) has announced its execution of ... Debt & Liabilities Agreement with Cannabics, Inc. a Delaware Corporation, ... the company. --> --> ... internal restructuring of the Company, whereby the Research and ...
Breaking Medicine Technology:
... 2011 Hospira, Inc. (NYSE: HSP ), a ... that the company will present at the Sanford C. Bernstein ... in New York. The presentation is scheduled to ... 2011.  It will be available to all interested parties through ...
... May 12, 2011 Men and women infected with ... their sexual partners through initiation of oral antiretroviral therapy ... study conducted by the HIV Prevention Trials Network (HPTN), ... HIV through cutting-edge biomedical, behavioral, and structural interventions. ...
Cached Medicine Technology:
Gently curved shaft with blunt angled tip is ideal for chopping the lens during anterior chamber phacoemulsification....
5 mm curved hook with markings at 14 mm and 20 mm from tip. Flat serrated handle with polished finish. Overall length: 4.7 inches....
#2 10 mm hook. Flat serrated handle with polished finish. Overall length: 5.5 inches....
2.0 mm bulbous tip with 6 mm flat portion. Flat serrated handle with polished finish. Overall length: 5.4 inches. Most popular size or model....
Medicine Products: